检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:余红平[1] 曾小云[1] 仇小强[1] 徐顺清[2] 施侣元[3] 张晓蓉[4] 李媛媛[2]
机构地区:[1]广西医科大学公共卫生学院,南宁530021 [2]华中科技大学同济医学院环境医学研究所 [3]华中科技大学同济医学院公共卫生学院流行病与卫生统计学系 [4]湖北省肿瘤医院放疗科
出 处:《广西医科大学学报》2006年第3期355-358,共4页Journal of Guangxi Medical University
基 金:国家自然科学基金重大项目子课题(No.39990570);国家卫生部基金资助项目(3-1)
摘 要:目的:探讨XRCC1基因单核苷酸多态性与肺癌易感性的关系。方法:以聚合酶链反应-限制性酶切片断多态性方法分析了肺癌病例(n=104)和按性别、年龄频数配比的健康对照者(n=121)XRCC1基因Arg194Trp和Arg399Gln位点的多态性,并比较不同基因型与肺癌风险的关系。结果:XRCC1 Arg399 Arg和Arg399Gln基因型频率在对照组和病例组中的分布差异无统计学意义(P〉0.05);病例组XRCC1 Gln399Gln突变纯合子基因型频率为13.46%,高于对照组3.31%(P〈0.01)。与携带Arg 399 Arg野生纯合子基因型者比较,携带Gln399Gln突变纯合子基因型个体发生肺癌的风险增加6.11倍(校正OR=6.11,95%CI=1.70-22.0);携带Arg399Gln突变杂合子基因型者患肺癌风险无显著增加(校正OR=1.03,95%CI=0.60~1.78)。XRCC1 Arg194Arg、Arg194Trp和Trp194Trp基因型频率在对照组和病例组中的分布差异均无统计学意义(P〉0.05);与携带Arg194Arg野生纯合子基因型者比较,携带至少1个194Trp等位基因者(即Arg194Trp和Trp194Trp基因型)患肺癌风险无显著增加(校正OR:0.998,95%CI=0.97~1.03;校正OR=1.81,95%CI=0.30~11.08)。结论:DNA碱基切除修复基因XRCC1 Gln399Gln突变纯合子基因型者患肺痛风险增加.Objective:To investigate the correlation between XRCC1 genetic polymorphisms and susceptibility to human lung cancer. Methods:A hospital-based case-control study of lung cancer was conducted. The cases ( n = 104) were all newly diagnosed lung cancer in Wuhan, and healthy controls were matched to the cases in frequency on age(±5years)and sex ( n = 121). XRCC1 genotype was determined from blood-derived DNA using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Logistic regression analysis was performed to calculate the adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Result:For XRCC1 codon 399 genotypes, there is no significant difference between frequencies of the Arg/Arg and Arg/Gln among patients and controls ( P〉0.05), and Arg/Gln genotypes were not associated with risk (adjusted OR=1.03,95% CI =0.60-1.78) for lung cancer compared with Arg/ Arg genotype. Only the frequency of XRCC1 399 Gln/Gln genotype was higher in the cases (13.46%) than that in controls (3.31%) and associated with an increased risk (adjusted OR= 6.11, 95% CI= 1.70-22.0) for lung cancer compared with Arg/Arg genotype. Conclusion:DNA repair XRCC1 399 Gln/Gln genotype may increase risk of lung cancer.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15